OCRA News
Vulnerability in ARID1A-Mutant Cancer Cells Could Provide New Pathways for OCCC Treatment
OCRA grantees Dr. Rugang Zhang and Dr. Shuai Wu, both of The Wistar Institute, along with colleagues, have discovered a vulnerability in cancer cells that harbor certain genetic mutations…
Egg Freezing for Ovarian Cancer Patients
Fertility preservation is an important consideration for many young ovarian cancer patients and one common procedure is egg freezing. Here are common questions and considerations to take into account while making those decisions…
Urgent: Tell Your U.S. Representative to Support a $10 Million Increase to OCRP
On Friday, March 19, U.S…
The Overview: March 2021
The snow is (finally!) melting in the areas where many of us at OCRA work and live, the COVID vaccine is rolling out, and there is so much work being done to improve the lives of the ovarian cancer community … we can’t help but feel hopeful…
Ovarian Cancer Advocates Unite for Spring Advocacy Day
OCRA’s Spring Advocacy Day, held March 8-9, looked a little bit different this year. For starters, we met online rather than in Washington D.C…
OCRA Awards Prizes in Ovarian Cancer Research
Each year, OCRA honors individuals doing important and notable work in the ovarian cancer field with a research prize to help propel their future discoveries. Individuals are selected by members of OCRA’s Scientific Advisory Committee. Dr…
Paying it Forward While Paying Homage to Madeline Kahn | OCRA Heroes
Most people who dedicate their lives to raising awareness about ovarian cancer, or who dedicate a gift-giving occasion to raise funds for research, have a personal connection to the disease…
OCRA Rings in Spring with a Return to In-Person Fitness Fundraisers
Spring is almost here and we’re welcoming the warmer weather with a careful and creative return to in-person OCRA Heroes events, including Ovarian Cycle rides and other fitness fundraisers! And many events will still include virtual options…
Advocacy in Action: A Year in Ovarian Cancer Policy Progress
As we gear up for our first ever virtual Spring Advocacy Day — which will welcome more than 200 participants, double our usual crowd! — we couldn’t help but take a moment and look back…
A False Alarm, and a Wake-Up Call to Fight Ovarian Cancer
Imagine, if you will, a scene from yesteryear: rows of telephone operators sitting in front of giant switchboards, lights blinking on and off in seemingly random patterns, hands working quickly to plug and unplug wires in order to foster…
Medicare Patients Pay High Cost for PARP Inhibitors
PARP inhibitors have proven to be particularly valuable in improving progression-free survival for patients with certain types of ovarian cancer…
How is Ovarian Cancer Diagnosed?
There are several types of ovarian cancer, and while they may have different origins, treatments, and prognosis, they all affect the ovaries and can be diagnosed with similar tests and procedures…